Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies.
about
Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trialExcitatory amino acid inhibitors for traumatic brain injuryHistorical Review of the Fluid-Percussion TBI ModelNeuroprotective agents in traumatic brain injuryImproving on Laboratory Traumatic Brain Injury Models to Achieve Better Results.Mechanical strain injury increases intracellular sodium and reverses Na+/Ca2+ exchange in cortical astrocytes.Animal models of traumatic brain injury: a review.Traumatic brain injury: developmental differences in glutamate receptor response and the impact on treatment.Attenuation of brain nitrostative and oxidative damage by brain cooling during experimental traumatic brain injury.Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury.Traumatic brain injury and its effects on synaptic plasticity.Outcome prediction within twelve hours after severe traumatic brain injury by quantitative cerebral blood flow.Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model.Critical appraisal of neuroprotection trials in head injury: what have we learned?Severe head injury and the risk of early death.Caspase inhibitors as neuroprotective agents.Cognitive evaluation of traumatically brain-injured rats using serial testing in the Morris water maze.Tissue sparing and functional recovery following experimental traumatic brain injury is provided by treatment with an anti-myelin-associated glycoprotein antibody.Voltage-gated calcium channel antagonists and traumatic brain injury.Dosing and safety of cyclosporine in patients with severe brain injury.Contemporary pharmacologic issues in the management of traumatic brain injury.Neuroinflammation: beneficial and detrimental effects after traumatic brain injury.Blockade of N-acetylaspartylglutamate peptidases: a novel protective strategy for brain injuries and neurological disorders.Role of Wnt Signaling in Central Nervous System Injury.Expression of Dixdc1 and its Role in Astrocyte Proliferation after Traumatic Brain Injury.NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in ratsNAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxiaPost-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBINAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat.Trauma-induced cell swelling in cultured astrocytes.Downregulation of glial scarring after brain injury: the effect of purine nucleoside analogue ribavirin.Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production.The expression of CAP1 after traumatic brain injury and its role in astrocyte proliferation.Impaired motor learning and diffuse axonal damage in motor and visual systems of the rat following traumatic brain injury.
P2860
Q21195018-5E5D8A6C-7864-4C63-B230-F91E79213C59Q24250201-F94F2662-9793-45DF-897B-1E4D4CD0565DQ28075670-0E78096E-BAA9-4EF8-9B07-74A90FA949C2Q28209606-AF3D8835-8DC0-499A-95DD-316EC9A3B5F8Q33717193-3147DE43-F004-4FC5-9E46-83BD5A3F61ABQ34374927-EFF7092C-F51C-46C0-90F7-4EFBC507238BQ34434470-1A93680B-1E72-462D-97E5-6046FA3DA432Q34469194-3B4B5B50-CBD9-4BDF-B39A-97FDC31D1B44Q34557422-CFAAA749-CFC4-49BE-88DC-88513DE79716Q35126001-FEE5341F-EF32-47EA-87D1-BEC6AB7C8BC5Q35173229-D2AEF4CF-0059-43C0-9EFA-ED74A6F4C917Q35828286-8243B5AA-D2AC-4BBB-9982-7DA805CBAA93Q35967863-262A2B68-E538-4669-8597-E6DDC3A531BAQ36045228-59A8A0B4-33EF-49B7-A616-C3BBD5007EDCQ36143148-E6BC3C13-68A6-4C27-94A9-97A130947286Q36179653-4BDB33C6-7732-49F8-BB01-E3285CEF9133Q36631065-41EF3305-B1F0-41DE-9327-E5DCBDE01333Q36649703-295FF9EA-E555-4257-8D14-D4112388F282Q37277428-B0458F77-DA17-445B-BEDF-D52E09770F33Q37406207-2C2C18F7-7460-4C4B-AD03-310DEC0B53E4Q37867299-3FFF5A6E-0861-4FF2-BD73-03E294FEE165Q38072367-833A8F09-C7F8-4244-A5D6-5817195CF19CQ38185090-4F0F7636-5744-4E73-89B2-30E92EDCF49BQ38481453-935211AB-901D-48CB-9ABD-4AACFA2268DFQ39165742-4E25E3A3-D22D-4714-BEF3-41669DD16071Q41995595-D23EAFEE-AE81-43EA-8E66-6666DEAF7ECFQ42285300-B29ACC58-73F0-4148-9B24-F37B911F6461Q42742435-382C69DE-18BD-4F67-BB6C-BC00FC02BC37Q46142561-FAB1A414-1A3C-49EB-B846-08A29122F6E2Q46630972-F45BC647-9EFA-4322-8D23-641891B9FEA8Q46696844-D338CE30-B8C1-4E95-B7F0-E3C16DEC591BQ48494172-447AFB41-2918-42C7-9942-1D0B4D5A1366Q48638558-D94AE0E6-15A0-4169-B332-0E3E552B3277Q48902857-D2BE860F-E106-48DD-94DA-E959591B340B
P2860
Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Current status of neuroprotect ...... l models and clinical studies.
@ast
Current status of neuroprotect ...... l models and clinical studies.
@en
type
label
Current status of neuroprotect ...... l models and clinical studies.
@ast
Current status of neuroprotect ...... l models and clinical studies.
@en
prefLabel
Current status of neuroprotect ...... l models and clinical studies.
@ast
Current status of neuroprotect ...... l models and clinical studies.
@en
P2093
P2860
P1433
P1476
Current status of neuroprotect ...... l models and clinical studies.
@en
P2093
Bullock MR
Muizelaar JP
P2860
P304
207-17; discussion 217-20
P356
10.1097/00006123-199908000-00001
P407
P577
1999-08-01T00:00:00Z